[1]UN Joint Programme on HIV/AIDS (UNAIDS),SThe Gap Report, 2014,Savailable at: http://www.refworld.org/docid/53f1e1604.html [2]Choudhary S K, Margolis D M. Curing HIV: Pharmacologic approaches to target HIV-1 latency[J]. Annual review of pharmacology and toxicology, 2011, 51(51): 397-418. [3]Van Lint C, Bouchat S, Marcello A. HIV-1 transcription and latency: an update[J]. Retrovirology, 2013, 10(1): 1. [4]Moore A L, Youle M, Lipman M, et al. Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure[J]. Aids, 2002, 16(4): 615-618. [5]Kahn P. From genome to proteome: looking at a cell's proteins[J]. Science, 1995, 270(5235): 369. [6]Elzek M A, Rodland K D. Proteomics of ovarian cancer: functional insights and clinical applications[J]. Cancer and Metastasis Reviews, 2015, 34(1): 83-96. [7]Ebhardt H A, Root A, Sander C, et al. Applications of targeted proteomics in systems biology and translational medicine[J].Proteomics,2015,15(18): 3193-3208. [8]Yan X, Yuan F, Chen X, et al. Bioinformatics analysis to identify the differentially expressed genes of glaucoma[J]. Molecular medicine reports,2015, 12(4):4829-4836. [9]袁鲁娜,李一鹏,刘瑞娟.哮喘患者吸入糖皮质激素前后血清蛋白质组变化及意义[J].世界最新医学信息文摘(电子版), 2016,16(24):51-52. [10] 王佐广,彭晓云,李梅,等.缬沙坦治疗原发性高血压患者血浆蛋白质组研究[J]. 中华老年心脑血管病杂志, 2014,16(4):343-348. [11] Yang H, Qiao H, Tian X. Proteomic analysis of cerebral synaptosomes isolated from rat model of Alzheimer’s disease[J]. Indian Journal of Experimental Biology,2011,49(2):118-24. [12] 邓敬桓,陈智平,李山,等.应用 SELDI-TOF-MS 技术筛选肝癌遗传性血清蛋白标志物[J]. 世界华人消化杂志, 2014,22(05):690-694. [13] 王子赫,刘晓晴.MALDI-TOF 质谱技术在肺癌中的应用[J]. 国际肿瘤学杂志, 2014, 41(005):344-347. [14] 范乃军,魏东,赵艇.应用磁珠联合质谱技术建立胃癌诊断模型[J]. 中华实验外科杂志, 2014, 31(011):2559-2561. [15] 熊万成,高春芳,范乃军.应用液体蛋白芯片-飞行时间质谱系统研究乳腺癌血清差异蛋白表达[J]. 河南科技大学学报(医学版),2014,32(02):89-93. [16] Stein D R, Burgener A, Ball T B. Proteomics as a novel HIV immune monitoring tool[J]. Current Opinion in HIV and AIDS, 2013, 8(2): 140-146. [17] Pratt R D, Nichols S, McKinney N, et al. Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children[J]. Journal of Infectious Diseases, 1996, 174(2): 288-293. [18] Stein D R, Burgener A, Ball T B. Proteomics as a novel HIV immune monitoring tool[J]. Current Opinion in HIV and AIDS, 2013, 8(2): 140-146. [19] Nyman T A, Matikainen S. Proteomics to study macrophage response to viral infection[J]. Journal of Proteomics, 2017. [20] Zhang L, Jia X, Jin J O, et al. Recent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders[J]. Genomics, proteomics bioinformatics, 2017, 15(2):110-120. [21] Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand[J]. New England Journal of Medicine, 2009, 361(23): 2209-2220. [22] He F, Zeng Y, Wu X, et al. Endogenous HIV-1 Vpr-mediated apoptosis and proteome alteration of human T-cell leukemia virus-1 transformed C8166 cells[J]. Apoptosis, 2009, 14(10): 1212-1226. [23] Naji S, Ambrus G, Cimerman?i? P, et al. Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production[J]. Molecular Cellular Proteomics, 2012, 11(4): M111. 015313. [24] Jaeger S, Cimermancic P, Gulbahce N, et al. Global landscape of HIV-human protein complexes[J]. Nature, 2012, 481(7381): 365-370. [25] Yang W, Zhou J Y, Chen L, et al. Glycoproteomic analysis identifies human glycoproteins secreted from HIV latently infected T cells and reveals their presence in HIV+ plasma[J]. Clinical proteomics, 2014, 11(1): 1. [26] Nguyen E V, Gharib S A, Crothers K, et al. Proteomic landscape of bronchoalveolar lavage fluid in human immunodeficiency virus infection[J]. American Journal of Physiology-Lung Cellular and Molecular Physiology, 2014, 306(1): L35-L42. [27] Wiederin J L, Donahoe R M, Anderson J R, et al. Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques[J]. Journal of proteome research, 2010, 9(9): 4721-4731. [28] Wiederin J L, Yu F, Donahoe R M, et al. Changes in the plasma proteome follows chronic opiate administration in simian immunodeficiency virus infected rhesus macaques[J]. Drug and alcohol dependence, 2012, 120(1): 105-112. [29] Cantres-Rosario Y M, Acevedo-Mariani F M, Pérez-Laspiur J, et al. Microwave magnetic proteomics of macrophages from patients with HIV-associated cognitive impairment[J]. PLoS One, 2017, 12(7): e0181779. [30] 孟庆宏,王常松,傅晓晴,刘清华,俞洁,闵莉.蛋白质组学技术引入中医证理论的可行性研究[J].中医学报, 2011, 26(2):170-172. [31] 袁宏伟,杜武勋,朱明丹,姜民,刘长玉.冠心病心气虚弱证/心肾阴虚证血清蛋白质组学特征研究[J].时珍国医国药, 2012,23(4):1014-1016. [32] 王刚,姜民,朱明丹,崔佩佩,杜武勋,范应昌,罗国安.冠心病心血瘀阻证和心肾阴虚证的蛋白组学研究[J].辽宁中医杂志, 2011,38;No.406(3):405-407. [33] 朱明丹,杜武勋,姜民,刘长玉,张建平,张红霞,刘岩,袁宏伟,曹旭焱.冠心病不同证候的蛋白质组学研究[J].辽宁中医杂志, 2013,v.40;No.434(07):1296-1301. [34] 曾绍谦,冯广帅,曹春辉,潘玲,冯全生.艾滋病热毒蕴结证的蛋白组学初探[A]. 中华中医药学会.中华中医药学会2015年防治艾滋病学术年会论文集[C].中华中医药学会:2015:5. [35] 邢静.艾滋病热毒蕴结证与脾肾阳虚证差异蛋白质表达的研究[D].成都中医药大学,2015. [36] 郭文利,舒发明,秦冰,苏姣,冯全生.艾滋病热毒蕴结证蛋白组学标志物验证研究[J].四川中医, 2016,34(08):60-61. [37] Marco A D, Kr?usslich H G, Briggs J A G. Structural Biology of HIV Assembly[M]// Advances in HIV-1 Assembly and Release. Springer New York, 2013:1-22.
|